• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

FDA's Global Strategy Against Counterfeit Medications

Article

Earlier this month, the FDA took steps to prevent the online sale of counterfeit and illegal medicinal products, which can be a significant health risk to the population.

Earlier this month, the FDA took steps to prevent the online sale of counterfeit and illegal medicinal products, which can be a significant health risk to the population.

Operation Pangea VIII, which spanned 115 countries, resulted in more than 2400 websites being taken offline and the seizure of $81 million worth of potential dangerous illegal medicines and medical devices worldwide. The current effort was a part of FDA's Global Strategic Framework for counterfeit and substandard medical products that strives to protect consumers by reducing their exposure to counterfeit and substandard medical products.

Read more about the FDA's effort on FDAVoice.

Related Videos
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Amit Singal, MD, UT Southwestern Medical Center
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Rashon Lane, PhD, MA
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Beau Raymond, MD
Binod Dhakal, MD, Medical College of Wisconsin, lead CARTITUDE-4 investigator
Dr Sophia Humphreys
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.